TRVI Insider Trading

Insider Ownership Percentage: 24.37%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $349,116.96

Trevi Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Trevi Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Trevi Therapeutics Share Price & Price History

Current Price: $4.05
Price Change: Price Decrease of -0.1 (-2.41%)
As of 12/20/2024 06:45 PM ET

This chart shows the closing price history over time for TRVI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Trevi Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/9/2024Jennifer L GoodCEOSell1,840$3.04$5,593.60213,313View SEC Filing Icon  
9/6/2024Jennifer L GoodCEOSell4,219$3.03$12,783.57213,313View SEC Filing Icon  
9/4/2024Jennifer L GoodCEOSell10,981$3.02$33,162.62213,313View SEC Filing Icon  
8/27/2024David P MeekerDirectorSell4,555$2.93$13,346.15352,489View SEC Filing Icon  
8/16/2024Thomas SciasciaInsiderSell18,660$2.76$51,501.60220,315View SEC Filing Icon  
8/14/2024Thomas SciasciaInsiderSell100$2.75$275.00220,315View SEC Filing Icon  
5/29/2024Thomas SciasciaInsiderSell53,368$2.55$136,088.40214,433View SEC Filing Icon  
5/22/2024Lisa DelfiniCFOSell4,350$2.64$11,484.0053,279View SEC Filing Icon  
5/20/2024Jennifer L GoodCEOSell25,037$2.86$71,605.82213,313View SEC Filing Icon  
5/10/2024Jennifer L GoodCEOSell4,578$2.90$13,276.20213,313View SEC Filing Icon  
10/11/2023Lisa DelfiniCFOSell785$2.02$1,585.7035,901View SEC Filing Icon  
9/11/2023Lisa DelfiniCFOSell711$2.20$1,564.2034,394View SEC Filing Icon  
8/11/2023Lisa DelfiniCFOSell682$2.36$1,609.5232,814View SEC Filing Icon  
7/11/2023Lisa DelfiniCFOSell687$2.34$1,607.5831,204View SEC Filing Icon  
6/12/2023Lisa DelfiniCFOSell610$2.64$1,610.4029,599View SEC Filing Icon  
4/11/2023Lisa DelfiniCFOSell840$1.84$1,545.6026,189View SEC Filing Icon  
3/13/2023Lisa DelfiniCFOSell892$1.75$1,561.0024,737View SEC Filing Icon  
2/13/2023Lisa DelfiniCFOSell8,474$2.45$20,761.3023,338View SEC Filing Icon  
7/5/2022Tpg Gp A, LlcMajor ShareholderSell63,569$3.11$197,699.593,824,883View SEC Filing Icon  
7/1/2022Tpg Gp A, LlcMajor ShareholderSell436,431$2.86$1,248,192.663,888,452View SEC Filing Icon  
6/29/2022Tpg Gp A, LlcMajor ShareholderSell46,128$2.74$126,390.724,754,721View SEC Filing Icon  
5/2/2022Tpg Gp A, LlcMajor ShareholderSell600$2.70$1,620.004,800,849View SEC Filing Icon  
4/28/2022Tpg Gp A, LlcMajor ShareholderSell7,271$2.77$20,140.674,817,612View SEC Filing Icon  
4/11/2022Paul Edward WalkerMajor ShareholderBuy3,580,526$1.90$6,802,999.4010,421,428View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Trevi Therapeutics (NASDAQ:TRVI)

95.76% of Trevi Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TRVI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Trevi Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC95,232$0.32M0.0%+180.8%0.124%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,264,166$4.22M0.0%+10.2%1.645%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC95,232$0.32M0.0%+180.8%0.124%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC32,929$0.11M0.0%-50.4%0.043%Search for SEC Filing on Google Icon
11/15/2024State Street Corp952,912$3.18M0.0%+5.9%1.240%Search for SEC Filing on Google Icon
11/15/2024Checkpoint Capital L.P.250,000$0.84M0.4%-50.0%0.325%Search for SEC Filing on Google Icon
11/14/2024Fred Alger Management LLC76,544$0.26M0.0%N/A0.100%Search for SEC Filing on Google Icon
11/14/2024Ally Bridge Group NY LLC1,322,800$4.42M2.4%-10.3%1.721%Search for SEC Filing on Google Icon
11/14/2024Acuta Capital Partners LLC290,500$0.97M0.8%+11.7%0.378%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets11,930$40K0.0%+130.9%0.016%Search for SEC Filing on Google Icon
11/9/2024Landscape Capital Management L.L.C.424,725$1.42M0.1%-29.8%0.585%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC18,914$63K0.0%N/A0.026%Search for SEC Filing on Google Icon
11/7/2024MAI Capital Management1,327,285$4.43M0.0%+0.7%1.828%Search for SEC Filing on Google Icon
11/6/2024Oppenheimer & Co. Inc.81,947$0.27M0.0%+34.7%0.113%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP122,447$0.41M0.0%N/A0.169%Search for SEC Filing on Google Icon
10/30/2024Rosalind Advisors Inc.750,000$2.51M1.6%-46.1%1.033%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC23,405$78K0.0%N/A0.033%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company24,524$73K0.0%+87.6%0.035%Search for SEC Filing on Google Icon
8/14/2024Logos Global Management LP2,800,000$8.34M0.7%+27.3%3.975%Search for SEC Filing on Google Icon
8/14/2024Ally Bridge Group NY LLC1,474,926$4.40M2.6%N/A2.094%Search for SEC Filing on Google Icon
8/13/2024Rubric Capital Management LP5,026,931$14.98M0.4%-9.7%7.137%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC19,612$61K0.0%N/A0.028%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC51,900$0.16M0.0%-55.6%0.074%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP72,210$0.22M0.0%+217.6%0.103%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.54,108$0.16M0.0%+17.1%0.077%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers75,218$0.22M0.0%+44.8%0.107%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp178,511$0.53M0.0%+38.8%0.253%Search for SEC Filing on Google Icon
7/12/2024Rosalind Advisors Inc.1,391,577$4.15M3.0%+50.3%1.976%Search for SEC Filing on Google Icon
5/29/2024Opaleye Management Inc.2,645,000$9.13M2.0%+4.3%3.756%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD13,561$47K0.0%N/A0.019%Search for SEC Filing on Google Icon
5/14/2024Propel Bio Management LLC260,000$0.90M0.5%N/A0.369%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,303,648$7.95M0.0%+2.7%3.271%Search for SEC Filing on Google Icon
5/7/2024Oppenheimer & Co. Inc.60,415$0.21M0.0%N/A0.086%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC14,592$50K0.0%-85.1%0.021%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets20,577$71K0.0%-84.4%0.030%Search for SEC Filing on Google Icon
4/25/2024Rosalind Advisors Inc.926,016$3.20M3.0%-50.3%1.343%Search for SEC Filing on Google Icon
2/15/2024Opaleye Management Inc.2,535,000$3.40M0.9%+48.6%3.970%Search for SEC Filing on Google Icon
2/15/2024Frazier Life Sciences Management L.P.7,381,090$9.89M0.5%+7.3%11.559%Search for SEC Filing on Google Icon
2/5/2024WealthTrust Axiom LLC63,500$85K0.0%-32.1%0.099%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC98,253$0.13M0.0%+401.4%0.154%Search for SEC Filing on Google Icon
1/4/2024Trust Co. of Toledo NA OH36,502$49K0.0%-68.8%0.057%Search for SEC Filing on Google Icon
11/13/2023Silverarc Capital Management LLC927,415$2.02M0.6%+4.7%1.452%Search for SEC Filing on Google Icon
10/20/2023Trust Co. of Toledo NA OH117,145$0.26M0.1%-6.2%0.183%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC19,597$43K0.0%N/A0.031%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC14,052$34K0.0%N/A0.022%Search for SEC Filing on Google Icon
8/11/2023VR Adviser LLC3,422,397$8.18M1.3%+12.2%5.697%Search for SEC Filing on Google Icon
8/11/2023Tejara Capital Ltd180,227$0.43M0.2%-5.3%0.300%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.20,037$48K0.0%N/A0.033%Search for SEC Filing on Google Icon
8/3/2023Innovis Asset Management LLC43,232$0.10M0.0%-50.5%0.072%Search for SEC Filing on Google Icon
8/2/2023MAI Capital Management1,534,652$3.67M0.1%-4.1%2.555%Search for SEC Filing on Google Icon
7/10/2023Trust Co. of Toledo NA OH124,857$0.30M0.1%+50.4%0.208%Search for SEC Filing on Google Icon
5/12/2023Tejara Capital Ltd190,218$0.35M0.2%+26.8%0.317%Search for SEC Filing on Google Icon
5/10/2023MAI Capital Management1,600,415$2.96M0.0%-7.0%2.664%Search for SEC Filing on Google Icon
4/4/2023Trust Co. of Toledo NA OH83,000$0.15M0.0%N/A0.138%Search for SEC Filing on Google Icon
2/10/2023Opaleye Management Inc.485,000$0.94M0.3%N/A0.809%Search for SEC Filing on Google Icon
2/9/2023MAI Capital Management1,720,676$3.32M0.1%-14.8%2.872%Search for SEC Filing on Google Icon
2/3/2023Frazier Life Sciences Management L.P.6,663,590$12.86M0.8%+23.3%11.121%Search for SEC Filing on Google Icon
2/2/2023Bailard Inc.21,200$41K0.0%N/A0.035%Search for SEC Filing on Google Icon
2/1/2023Bank of Montreal Can152,300$0.29M0.0%N/A0.254%Search for SEC Filing on Google Icon
11/15/2022TPG GP A LLC251,780$0.39M0.0%-94.2%0.571%Search for SEC Filing on Google Icon
11/14/2022Armistice Capital LLC864,000$1.33M0.0%+107.7%1.961%Search for SEC Filing on Google Icon
11/14/2022Altium Capital Management LP1,066,157$1.64M0.6%-17.0%2.419%Search for SEC Filing on Google Icon
11/14/2022Rubric Capital Management LP5,684,420$8.75M0.4%+219.6%12.899%Search for SEC Filing on Google Icon
11/10/2022Hillsdale Investment Management Inc.86,531$0.13M0.0%N/A0.196%Search for SEC Filing on Google Icon
11/9/2022Fairmount Funds Management LLC5,696,515$8.77M1.5%+250.7%12.926%Search for SEC Filing on Google Icon
11/7/2022Jump Financial LLC42,977$66K0.0%N/A0.098%Search for SEC Filing on Google Icon
10/28/2022Silverarc Capital Management LLC939,265$1.45M0.5%N/A2.131%Search for SEC Filing on Google Icon
8/15/2022Acuta Capital Partners LLC35,000$98K0.1%N/A0.090%Search for SEC Filing on Google Icon
8/10/2022Frazier Life Sciences Management L.P.1,171,627$3.29M0.3%N/A3.029%Search for SEC Filing on Google Icon
7/27/2022WealthTrust Axiom LLC93,500$0.26M0.1%-5.1%0.242%Search for SEC Filing on Google Icon
7/19/2022MAI Capital Management2,040,009$5.73M0.1%+32.3%5.273%Search for SEC Filing on Google Icon
5/10/2022MAI Capital Management1,541,471$3.39M0.1%N/A3.985%Search for SEC Filing on Google Icon
5/9/2022WealthTrust Axiom LLC98,500$0.22M0.1%+245.6%0.255%Search for SEC Filing on Google Icon
5/4/2022Commonwealth Equity Services LLC15,000$33K0.0%N/A0.049%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC34,600$78K0.0%-68.4%0.160%Search for SEC Filing on Google Icon
8/16/2021Alberta Investment Management Corp25,000$56K0.0%N/A0.116%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC92,600$0.21M0.0%-24.0%0.429%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC10,617$29K0.0%N/A0.053%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC10,617$29K0.0%N/A0.053%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC121,849$0.33M0.0%+374.1%0.611%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.32,394$87K0.0%+40.6%0.163%Search for SEC Filing on Google Icon
4/14/2021WealthTrust Axiom LLC38,500$0.10M0.0%+234.8%0.193%Search for SEC Filing on Google Icon
3/26/2021Susquehanna International Group LLP14,828$36K0.0%N/A0.081%Search for SEC Filing on Google Icon
2/17/2021Canada Pension Plan Investment Board15,000$36K0.0%N/A0.082%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC25,700$62K0.0%N/A0.140%Search for SEC Filing on Google Icon
2/4/2021WealthTrust Axiom LLC11,500$27K0.0%N/A0.063%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Trevi Therapeutics logo
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC) conditions targeting the central and peripheral nervous systems. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase 2b Cough Reduction in IPF with nalbuphine ER (CORAL) clinical trial for treatment of chronic cough in patients with IPF; phase 2a Refractory Chronic Cough Improvement Via NAL ER (RIVER) clinical trial for reducing chronic cough in RCC patients; phase 2 clinical trial in patients with pruritus; phase 2b/3 clinical trial in patients with prurigo nodularis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.
Read More on Trevi Therapeutics

Today's Range

Now: $4.05
Low: $4.05
High: $4.39

50 Day Range

MA: $3.11
Low: $2.49
High: $4.50

52 Week Range

Now: $4.05
Low: $1.27
High: $4.68

Volume

1,741,543 shs

Average Volume

617,816 shs

Market Capitalization

$311.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.96

Who are the company insiders with the largest holdings of Trevi Therapeutics?

Trevi Therapeutics' top insider investors include:
  1. David P Meeker (Director)
  2. Thomas Sciascia (Insider)
  3. Jennifer L Good (CEO)
  4. Lisa Delfini (CFO)
Learn More about top insider investors at Trevi Therapeutics.

Who are the major institutional investors of Trevi Therapeutics?

Trevi Therapeutics' top institutional shareholders include:
  1. MAI Capital Management — 1.83%
  2. Ally Bridge Group NY LLC — 1.72%
  3. Geode Capital Management LLC — 1.64%
  4. State Street Corp — 1.24%
  5. Rosalind Advisors Inc. — 1.03%
  6. Landscape Capital Management L.L.C. — 0.59%
Learn More about top institutional investors of Trevi Therapeutics stock.

Which major investors are selling Trevi Therapeutics stock?

In the last quarter, TRVI stock was sold by these institutional investors:
  1. Rosalind Advisors Inc.
  2. Checkpoint Capital L.P.
  3. Landscape Capital Management L.L.C.
  4. Ally Bridge Group NY LLC
  5. Jane Street Group LLC
During the last year, company insiders that have sold Trevi Therapeutics company stock include:
  1. David P Meeker (Director)
  2. Thomas Sciascia (Insider)
  3. Jennifer L Good (CEO)
  4. Lisa Delfini (CFO)
Learn More investors selling Trevi Therapeutics stock.

Which major investors are buying Trevi Therapeutics stock?

Within the last quarter, TRVI stock was purchased by institutional investors including:
  1. GSA Capital Partners LLP
  2. Geode Capital Management LLC
  3. Fred Alger Management LLC
  4. Barclays PLC
  5. Barclays PLC
  6. State Street Corp
  7. Acuta Capital Partners LLC
  8. SG Americas Securities LLC